Monoclonal Antibodies Prevent HIV in Proof-of-Concept Trial Monoclonal Antibodies Prevent HIV in Proof-of-Concept Trial

The phase 2b study lays out a path toward developing monoclonal antibody drugs for passive prevention of HIV. It also paves the way toward developing a biomarker for predicting success.Medscape Medical News
Source: Medscape Hiv-Aids Headlines - Category: Infectious Diseases Tags: HIV/AIDS News Source Type: news